Midkine regulation of the renin-angiotensin system

Current Hypertension Reports

Volumn 12, Issue 2, 2010, Pages 74-79

  Kadomatsu, Kenji ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic kidney disease; Hypertension; Midkine; Renin angiotensin system

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DIPEPTIDYL CARBOXYPEPTIDASE; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HYDRALAZINE; MIDKINE; OLMESARTAN; PLEIOTROPHIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TEMOCAPRIL;

AMINO ACID SEQUENCE; ANGIOGENESIS; ANTISENSE THERAPY; ASTROCYTOMA; BIOLOGICAL ACTIVITY; BLADDER CANCER; CANCER GENE THERAPY; CANCER GROWTH; CARCINOGENESIS; CELL SURVIVAL; CHRONIC KIDNEY DISEASE; COLORECTAL CANCER; COLORECTAL CARCINOMA; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; EMBRYO DEVELOPMENT; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HEART PROTECTION; HUMAN; HYPERTENSION; IMMUNOPATHOGENESIS; INFLAMMATION; INTERSTITIAL NEPHRITIS; KIDNEY INJURY; LUNG PARENCHYMA; NEPHRECTOMY; NERVE CELL DIFFERENTIATION; NEUROFIBROMA; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESTENOSIS; REVIEW; RHEUMATOID ARTHRITIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; UPREGULATION;

ACETYLCHOLINESTERASE; ACUTE KIDNEY INJURY; ALDOSTERONE; ANGIOTENSIN II; ANIMALS; CENTRAL NERVOUS SYSTEM; CYTOKINES; FIBROBLAST GROWTH FACTORS; HUMANS; HYPERTENSION; INFLAMMATION; KIDNEY FAILURE, CHRONIC; LUNG; MICE; RECEPTORS, FIBROBLAST GROWTH FACTOR; RENIN; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS;

EID: 77953535068     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-010-0092-8     Document Type: Review

References (18)

1. Ferrari P: Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease. Nephrology 2007, 12:81-89.
2. Werner C, Baumhakel M., Teo K.K., et al.: RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection. Clin Res Cardiol 2008, 97:418-431.
3. Wuhl E, Schaefer F: Therapeutic strategies to slow chronic kidney disease progression. Pediatr Nephrol 2008, 23:705-716.
4. Amann K, Wanner C., Ritz E: Cross-talk between the kidney and the cardiovascular system. J Am Soc Nephrol 2006, 17:2112-2119.
5. Nishimura M, Takahashi H., Yoshimura M: Upregulation of the brain renin-angiotensin system in rats with chronic renal failure. Acta Physiol 2007, 189:369-377.
6. Hoke TS, Douglas IS, Klein C.L., et al.: Acute renal failure after bilateral nephrectomy is associated with cytokine-mediated pulmonary injury. J Am Soc Nephrol 2007, 18:155-164.
7. Hobo A, Yuzawa Y., Kosugi T., et al.: The growth factor midkine regulates the renin-angiotensin system in mice. J Clin Invest 2009, 119:1616-1625.
8. Neuhofer W, Pittrow D: Endothelin receptor selectivity in chronic kidney disease: rationale and review of recent evidence. Eur J Clin Invest 2009, 39(Suppl 2):50-67.
9. Upton PD, Morrell NW: TGF-beta and BMPR-II pharmacology - implications for pulmonary vascular diseases. Curr Opin Pharmacol 2009, 9:274-280.
10. Krapf R, Hulter HN: Arterial hypertension induced by erythropoietin and erythropoiesis-stimulating agents (ESA). Clin J Am Soc Nephrol 2009, 4:470-480.
11. Nakagawa T: A new mouse model resembling human diabetic nephropathy: uncoupling of VEGF with eNOS as a novel pathogenic mechanism. Clin Nephrol 2009, 71:103-109.
12. Kadomatsu K, Muramatsu T: Midkine and pleiotrophin in neural development and cancer. Cancer Lett 2004, 204:127-143.
13. Vaziri ND, Rodriguez-Iturbe B: Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension. Nat Clin Pract Nephrol 2006, 2:582-593.
14. Ikematsu S, Nakagawara A., Nakamura Y., et al.: Plasma midkine level is a prognostic factor for human neuroblastoma. Cancer Sci 2008, 99:2070-2074.
15. Horiba M, Kadomatsu K., Yasui K., et al.: Midkine plays a protective role against cardiac ischemia/reperfusion injury through a reduction of apoptotic reaction. Circulation 2006, 114:1713-1720.
16. Sumida A, Horiba M., Ishiguro H., et al.: Midkine gene transfer after myocardial infarction in rats prevents remodeling and ameliorates cardiac dysfunction. Cardiovasc Res 2010 Jan 19 (Epub ahead of print).
17. Banno H, Takei Y., Muramatsu T., et al.: Controlled release of small interfering RNA targeting midkine attenuates intimal hyperplasia in vein grafts. J Vasc Surg 2006, 44:633-641.
18. Kaneda N, Talukder AH, Nishiyama H., et al: Midkine, a heparinbinding growth/differentiation factor, exhibits nerve cell adhesion and guidance activity for neurite outgrowth in vitro. J Biochem 1996, 119:1150-1156.